Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.

Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.

To study the prevalence of sustained intraocular pressure (IOP) elevation associated with intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents.Prospective comparative study. Non-glaucomatous patients scheduled to receive intravitreal injection of anti-VEGF therapy wer...

Full description

Bibliographic Details
Main Authors:	Weerawat Kiddee, Mayuree Montriwet
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4567346?pdf=render

Similar Items

Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy
by: Jeanette Du, et al.
Published: (2022-10-01)

Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure
by: Marc-Antoine Hannappe, et al.
Published: (2022-02-01)

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection
by: Mahmut Kaya, et al.
Published: (2021-01-01)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
by: Inès Ben Ghezala, et al.
Published: (2022-08-01)

Effect of intravitreal injection of anti-vascular endothelial growth factor agents on systemic concentration of vascular endothelial growth factor
by: Mei Wang, et al.
Published: (2023-04-01)

Can intravitreal injections with higher volume cause higher intraocular eye pressure? Considerations for anti-complement injections in normal and glaucomatous eyes
by: Carsten H. Meyer, et al.
Published: (2023-12-01)

Effect of fasting on intraocular pressure in glaucomatous patients
by: Walid Abdelghaffar, et al.
Published: (2020-01-01)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
by: Ruão M, et al.
Published: (2017-02-01)

Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline
by: Homayoun Nikkhah, et al.
Published: (2018-01-01)

Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure
by: Ashiyana Nariani, et al.
Published: (2016-01-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
by: Irini Chatziralli, et al.
Published: (2021-07-01)

Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome
by: Fahrettin Akay, et al.
Published: (2020-10-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
by: Abraham Hang, et al.
Published: (2023-08-01)

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
by: Manavi D Sindal, et al.
Published: (2021-01-01)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
by: Tzu-Yi Lin, et al.
Published: (2023-02-01)

Bilateral same-session intravitreal injections of anti-vascular endothelial growth factors
by: Nakhleh E. Abu-Yaghi, et al.
Published: (2014-12-01)

Intraocular Pressure during Spaceflight and Risk of Glaucomatous Damage in Prolonged Microgravity
by: Mouayad Masalkhi, et al.
Published: (2023-09-01)

Pre-operative intraocular pressure as a predictor of post-operative intraocular pressure after phacoemulsification in non-glaucomatous patients
by: Titiek Ernawati, et al.
Published: (2022-02-01)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
by: Rai BB, et al.
Published: (2023-06-01)

Intraocular pressure fluctuation and the risk of glaucomatous damage deterioration: a Meta-analysis
by: Zhen-Zhen Guo, et al.
Published: (2019-01-01)

Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema
by: Itou J, et al.
Published: (2023-01-01)

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of <i>Coats′ disease</i> in children
by: Kaul Shalini, et al.
Published: (2010-01-01)

Effect on Intraocular Pressure of Intravitreal Dexamethasone Implant
by: Muhammed Batur, et al.
Published: (2023-07-01)

On elevation of intraocular pressure after intravitreal injections
by: S. M. Bauer, et al.
Published: (2022-01-01)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
by: Jihyun Yoon, et al.
Published: (2021-06-01)

Response to treatment with intravitreal anti-vascular endothelial growth factors in bilateral exudative cuticular drusen
by: Yusuf K. Durlu, MD.
Published: (2021-06-01)

Comparison of the corrected intraocular pressure by tonopachy with that of Goldmann applanation tonometry in normal and glaucomatous patients
by: Girish Velis, et al.
Published: (2020-01-01)

Newer anti-vascular endothelial growth factor agents
by: Priya Rasipuram Chandrasekaran
Published: (2020-01-01)

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study
by: Lin Jiang, et al.
Published: (2023-02-01)

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
by: Lemos-Reis R, et al.
Published: (2014-07-01)

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
by: Eugene Yu-Chuan Kang, et al.
Published: (2023-03-01)

Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
by: Maiko Maruyama-Inoue, et al.
Published: (2023-04-01)

Nutritionally variant streptococci causing endophthalmitis associated with intravitreal anti-vascular endothelial growth factor injection
by: Robert L. Steinmetz, et al.
Published: (2021-03-01)

Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms
by: Caroline Bormann, et al.
Published: (2017-03-01)

Efficacy of as-needed intravitreal injection compared to 3-monthly loading of anti-vascular endothelial growth factor agents for branch retinal vein occlusion
by: Yoo-Ri Chung, et al.
Published: (2023-07-01)

Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity
by: Jing Chen, et al.
Published: (2023-01-01)

Twenty-four-hour repeatability of diurnal intraocular pressure patterns in glaucomatous and ocular hypertensive individuals
by: Marcelo Hatanaka, et al.
Published: (2011-01-01)

Effect of intravitreal anti-vascular endothelial growth factor on corneal endothelial cell count and central corneal thickness in Indian population
by: Mukesh Joshi, et al.
Published: (2019-01-01)

Long-Term Resolution of Perifoveal Exudative Vascular Anomalous Complex after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor
by: Nuria Torrell-Belzach, et al.
Published: (2022-11-01)

Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections
by: LoBue SA, et al.
Published: (2023-06-01)